Voyager Therapeutics (VYGR) Receives a Buy from Wells Fargo
I'm PortAI, I can summarize articles.
In a report released today, from Wells Fargo maintained a Buy rating on Voyager Therapeutics, with a price target of $10.00.Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow. Voyager Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $14.29.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments